Dr. David Epstein Joins Aerie Pharmaceuticals Advisory Board

Aerie Pharmaceuticals has named David Epstein, MD, a board-certified ophthalmologist, as chairman of the company's scientific advisory board.

Dr. Epstein is a co-founder of Aerie and chairman of Duke University's ophthalmology department.

Aerie has also named Vicente Anido, Jr., PhD, an ophthalmology industry expert, as its chairman of the board.

More Articles on Ophthalmology:
InSite Vision Receives $15M in Royalties for Pink-Eye Treatment
IRIDEX, Peregrine Surgical Partner
Dr. Kenneth Pearlberg Joins Medifirst Solutions Advisory Board

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast